Keyphrases
Multicenter AIDS Cohort Study
100%
Highly Active Antiretroviral Therapy (HAART)
100%
HIV-1 Infection
42%
Human Immunodeficiency Virus Type 1 (HIV-1)
28%
Age Groups
28%
Racial-ethnic Groups
28%
Specific Intent
28%
Race-ethnicity
28%
Chicago
28%
AIDS/HIV
14%
Natural History
14%
Executive Committee
14%
Core Laboratory
14%
African American Men
14%
Data Management
14%
Malignant Disease
14%
Collaborative Research
14%
Adverse Effects
14%
Host Genetics
14%
Viral Co-infection
14%
Hepatitis C
14%
Antiretroviral Adherence
14%
Slow Progressor
14%
HHV-8
14%
Cardiovascular Effects
14%
Epstein-Barr Virus
14%
Laboratory Capacity
14%
Virus Type
14%
Metabolic Side Effects
14%
Long-term Nonprogressors
14%
Active Participation
14%
Neurological Outcome
14%
Hispanic Men
14%
HIV Infection
14%
Neuropsychological Functioning
14%
Rapid Progressors
14%
Socioeconomic Status
14%
Resistance to Infection
14%
Innovative Methods
14%
Hepatitis B
14%
Highly Exposed
14%
Individual Response
14%
Treatment Effect
14%
Co-infection
14%
Medicine and Dentistry
Highly Active Antiretroviral Therapy
100%
Cohort Analysis
100%
Human Immunodeficiency Virus 1 Infection
42%
Human Immunodeficiency Virus
28%
Mixed Infection
28%
Ethnic Groups
28%
Adverse Effect
28%
Hepatitis B
14%
Hepatitis C
14%
Hepatitis G Virus
14%
Epstein Barr Virus
14%
Herpesviridae
14%
HIV/AIDS
14%
Racial Group
14%
Socioeconomic Status
14%
Patient Compliance
14%
Cardiovascular System
14%
Infection
14%
Human Immunodeficiency Virus Infection
14%
Diseases
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
HIV
75%
Human Immunodeficiency Virus 1 Infection
75%
Mixed Infection
50%
Epstein-Barr Virus
25%
Human Immunodeficiency Virus Infection
25%
Hepatitis B
25%
Hepatitis G Virus
25%
Infection
25%
Herpesviridae
25%
Hepatitis C
25%
Diseases
25%